Login
$MRVL
$233.78 +$5.27 (2.31%) Close

Unaudited condensed consolidated balance sheets

In millions of USD, except per-share amounts
Q2 FY2027
As of Aug 1, 2026
Q1 FY2027
As of May 2, 2026
Q4 FY2026
As of Jan 31, 2026
Q3 FY2026
As of Nov 1, 2025
Q2 FY2026
As of Aug 2, 2025
Q1 FY2026
As of May 3, 2025
Q4 FY2025
As of Feb 1, 2025
Q3 FY2025
As of Nov 2, 2024
Q2 FY2025
As of Aug 3, 2024
Q1 FY2025
As of May 4, 2024
Q4 FY2024
As of Feb 3, 2024
Q3 FY2024
As of Oct 28, 2023
Q2 FY2024
As of Jul 29, 2023
Q1 FY2024
As of Apr 29, 2023
Q4 FY2023
As of Jan 28, 2023
Q3 FY2023
As of Oct 29, 2022
Q2 FY2023
As of Jul 30, 2022
Q1 FY2023
As of Apr 30, 2022
Q4 FY2022
As of Jan 29, 2022
Q3 FY2022
As of Oct 30, 2021
ASSETS
Current assets:
Cash and cash equivalents
Accounts receivable, net
Inventories
Prepaid expenses and other current assets
Assets held for sale
Total current assets
Property and equipment, net
Goodwill
Acquired intangible assets, net
Deferred tax assets
Other non-current assets
Total assets
LIABILITIES AND STOCKHOLDERS’ EQUITY
Current liabilities:
Accounts payable
Accrued liabilities
Accrued employee compensation
Short-term debt
Total current liabilities
Long-term debt
Other non-current liabilities
Total liabilities
Stockholders’ equity:
Preferred stock, $0.002 par value; 8.0 shares authorized; 2.0 shares issued and outstanding as of August 1, 2026 of Series A Convertible Preferred Stock (none issued and outstanding as of January 31, 2026)
Common stock, $0.002 par value
Additional paid-in capital
Accumulated other comprehensive income
Retained earnings
Total stockholders’ equity
Total liabilities and stockholders’ equity

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support